retatrutide and addiction GLP-1 medications get at the heart of addiction: study – WashU Medicine Is a new weight-loss drug

GIP Receptor Activation Glucose-dependent insulinotropic polypeptide receptor activation adds metabolic benefits beyond appetite control

That is nearly one quarter of total body weight, gone

There are several mechanisms by which these drugs result in weight loss, with MOST of the effect being related to hunger and satiety

Organization of the human intestine at single-cell resolution

Obesity prevalence has doubled since 1990, with one in eight individuals being obese worldwide

In patients with type 2 diabetes inadequately controlled on metformin immediate-release alone, the overall incidence of adverse reactions of hypoglycemia was 1.3% in patients given add-on sitagliptin and 2.1% in patients given add-on placebo